JoAl Mayor, PharmD, BCOP
Seagen Inc.
4
0
4
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Michelle Ubowski, PharmD
Seagen Inc.
Shared therapeutic areas:
Worked with same sponsors:
Corinna Palanca-Wessels, MD, PhD
Seagen Inc.
Shared therapeutic areas:
Worked with same sponsors:
Manish Shah, M.D.
Weill Medical College of Cornell University
Shared therapeutic areas:
jiafu ji, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Jiafu Ji, M.D.
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Ajay Goel, PhD
City of Hope Medical Center
Shared therapeutic areas:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
lin shen, Professor
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Yelena Janjigian, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Manish Shah, MD
Weill Medical College of Cornell University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer
A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin
A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer
A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer
All 4 trials loaded